{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:23:55Z","timestamp":1785799435179,"version":"3.56.0"},"reference-count":22,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"unspecified","delay-in-days":11,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000982","name":"Conquer Cancer Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100000982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002224","name":"Melanoma Research Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100002224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2024,10,13]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>While the prognostic role of tertiary lymphoid structures (TLS) has been well studied in solid cancers, the prevalence and impact of immature precursor lymphoid structures known as lymphoid aggregates (LA) remain unresolved in relation to the disease process. In this study, we examined characteristics and the prognostic utility of LA and TLS status in histological samples from patients with melanoma.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We assessed The Cancer Genomic Atlas-skin cutaneous melanoma digital slides and melanoma specimens from the University of Pittsburgh for the presence of LA and TLS using H&amp;E staining, multiplex immunofluorescence (mIF) and transcriptomic analyses. Cox proportional hazard regression models were used to assess the prognostic value associated with the presence of lymphoid structures in melanomas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 278 evaluable samples were analyzed and split into primary melanomas in skin (N=195) and metastatic melanomas involving skin\/subcutaneous\/soft tissue sites (N=83). 72% of tumor specimens contained histologically defined LA located in peritumoral (34%), intratumoral (5.6%) or stromal (6.1%) locations, with the remaining samples (54.3%) exhibiting LA in multiple locations. In contrast to LA which tended to form more commonly in primary melanoma samples, TLS with germinal centers predominantly formed in peritumoral (45.2%) or stromal (35.5%) locations in metastatic melanomas (p=0.02), with TLS observed in 11% of all melanoma specimens evaluated. mIF analyses revealed cellular heterogeneity of lymphoid structures, with CD20<jats:sup>+<\/jats:sup> (B) cells present in nodule-shaped and stromal locations where they exhibited a high degree of colocalization with CD4<jats:sup>+<\/jats:sup> and CD8<jats:sup>+<\/jats:sup> T cells. A previously defined 12-chemokine gene expression score was significantly higher in samples with evidence of LA versus none (p&lt;0.001), and samples without LA\/TLS were enriched with pigmentation\/neural network gene signatures. The presence of LA was significantly associated with tumor-free regional lymph node status (p=0.002). In multivariable analysis, after adjusting for age, sex, sample type, and stage, the presence of LA was associated with improved patient overall survival (OS) (HR=0.52, 95%\u2009CI 0.31 to 0.87, p=0.01).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Melanoma frequently contains LA, which tends to form in diverse locations in the tumor microenvironment in association with improved overall survival and tumor-free regional lymph node status in patients with primary disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/jitc-2024-009231","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T00:50:18Z","timestamp":1731459018000},"page":"e009231","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Differences in the pathological, transcriptomic, and prognostic implications of lymphoid structures between primary and metastatic cutaneous melanomas"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8530-0907","authenticated-orcid":false,"given":"Lilit","family":"Karapetyan","sequence":"first","affiliation":[{"name":"Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aofei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pathology, Indiana University, Indianapolis, Indiana, USA"},{"name":"UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Vargas De Stefano","sequence":"additional","affiliation":[{"name":"Department of Pathology, Phoenix Children's Hospital, Phoenix, Arizona, USA"},{"name":"University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0068-5201","authenticated-orcid":false,"given":"Hassan M","family":"Abushukair","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan"},{"name":"Oncology Science, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA"},{"name":"Medical Oncology, OU Stephenson Cancer Center, Oklahoma City, Oklahoma, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8216-0400","authenticated-orcid":false,"given":"Ayah N","family":"Al-Bzour","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Knight","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Layding","sequence":"additional","affiliation":[{"name":"UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, USA"},{"name":"Graduate School of Public Health, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[{"name":"Graduate School of Public Health, University of Pittsburgh Graduate School of Public Health, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Xu","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center, Tampa, Florida, USA"},{"name":"Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiqiang","family":"Yao","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center, Tampa, Florida, USA"},{"name":"Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Song","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center, Tampa, Florida, USA"},{"name":"Department of Biostatistics and Bioinformatics, Moffitt Cancer Center & Research Institute, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Joy","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center Health System, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Pathology, H Lee Moffitt Cancer Center and Research Center Inc, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8702-0554","authenticated-orcid":false,"given":"Carlos","family":"Moran-Segura","sequence":"additional","affiliation":[{"name":"Pathology, H Lee Moffitt Cancer Center and Research Center Inc, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bruno","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cindy","family":"Sander","sequence":"additional","affiliation":[{"name":"UPMC, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Messina","sequence":"additional","affiliation":[{"name":"Department of Pathology, Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7354-0516","authenticated-orcid":false,"given":"James J","family":"Mule","sequence":"additional","affiliation":[{"name":"Moffitt Cancer Center, Tampa, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8961-4444","authenticated-orcid":false,"given":"Walter J","family":"Storkus","sequence":"additional","affiliation":[{"name":"Dermatology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"},{"name":"Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Kirkwood","sequence":"additional","affiliation":[{"name":"Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"2025100306400000000_12.11.e009231.1","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"2025100306400000000_12.11.e009231.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00619-z"},{"key":"2025100306400000000_12.11.e009231.3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41586-019-1922-8","article-title":"B cells and tertiary lymphoid structures promote immunotherapy response","volume":"577","author":"Helmink","year":"2020","journal-title":"Nature New Biol"},{"key":"2025100306400000000_12.11.e009231.4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/s41586-019-1914-8","article-title":"Tertiary lymphoid structures improve immunotherapy and survival in melanoma","volume":"577","author":"Cabrita","year":"2020","journal-title":"Nature New Biol"},{"key":"2025100306400000000_12.11.e009231.5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/s41586-019-1906-8","article-title":"B cells are associated with survival and immunotherapy response in sarcoma","volume":"577","author":"Petitprez","year":"2020","journal-title":"Nature New Biol"},{"key":"2025100306400000000_12.11.e009231.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.03.007"},{"key":"2025100306400000000_12.11.e009231.7","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23355-x","article-title":"B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma","volume":"12","author":"Ruffin","year":"2021","journal-title":"Nat Commun"},{"key":"2025100306400000000_12.11.e009231.8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.6149"},{"key":"2025100306400000000_12.11.e009231.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2023.08.009"},{"key":"2025100306400000000_12.11.e009231.10","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002273","article-title":"Heterogeneity in tertiary lymphoid structure B-cells correlates with patient survival in metastatic melanoma","volume":"9","author":"Lynch","year":"2021","journal-title":"J Immunother Cancer"},{"key":"2025100306400000000_12.11.e009231.11","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2164476","article-title":"Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomas","volume":"12","author":"Edmonds","year":"2023","journal-title":"Oncoimmunology"},{"key":"2025100306400000000_12.11.e009231.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2022.02.001"},{"key":"2025100306400000000_12.11.e009231.13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI67428"},{"key":"2025100306400000000_12.11.e009231.14","doi-asserted-by":"crossref","DOI":"10.1038\/srep00765","article-title":"12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?","volume":"2","author":"Messina","year":"2012","journal-title":"Sci Rep"},{"key":"2025100306400000000_12.11.e009231.15","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-021-00232-6"},{"key":"2025100306400000000_12.11.e009231.16","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(18)30078-0"},{"key":"2025100306400000000_12.11.e009231.17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/2326-6066.CIR-22-0110","article-title":"Sensory Nerves Impede the Formation of Tertiary Lymphoid Structures and Development of Protective Antimelanoma Immune Responses","volume":"10","author":"Vats","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"2025100306400000000_12.11.e009231.18","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1009234107"},{"key":"2025100306400000000_12.11.e009231.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.07.006"},{"key":"2025100306400000000_12.11.e009231.20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.157215","article-title":"CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancer","volume":"7","author":"Ukita","year":"2022","journal-title":"JCI Insight"},{"key":"2025100306400000000_12.11.e009231.21","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0952"},{"key":"2025100306400000000_12.11.e009231.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2006.04.006"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2024-009231","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T13:40:10Z","timestamp":1759498810000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2024-009231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":22,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,12]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/jitc-2024-009231"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2024-009231","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}